1. Home
  2. SDRL vs HAE Comparison

SDRL vs HAE Comparison

Compare SDRL & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seadrill Limited

SDRL

Seadrill Limited

HOLD

Current Price

$48.38

Market Cap

3.1B

Sector

Energy

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$54.98

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SDRL
HAE
Founded
2005
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
SDRL
HAE
Price
$48.38
$54.98
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$56.00
$84.13
AVG Volume (30 Days)
503.0K
631.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
54.61
44.54
EPS
N/A
2.46
Revenue
$1,437,000,000.00
$910,373,000.00
Revenue This Year
$5.22
N/A
Revenue Next Year
$16.68
$5.23
P/E Ratio
N/A
$22.17
Revenue Growth
3.75
N/A
52 Week Low
$22.30
$47.32
52 Week High
$50.24
$87.32

Technical Indicators

Market Signals
Indicator
SDRL
HAE
Relative Strength Index (RSI) 55.70 42.10
Support Level $28.68 $54.92
Resistance Level $49.61 $56.64
Average True Range (ATR) 1.23 2.73
MACD -0.18 -0.60
Stochastic Oscillator 54.90 41.01

Price Performance

Historical Comparison
SDRL
HAE

About SDRL Seadrill Limited

Seadrill Ltd is an offshore drilling contractor company. The company is engaged in providing offshore drilling services to the oil and gas industry. The primary business of the company is the ownership and operation of drillships, semi-submersible rigs, and jack-up rigs for operations in shallow to ultra-deepwater areas in both benign and harsh environments. The geographical segments of the company are the United States, Brazil, Angola, Norway, and others. The company derives maximum revenue from Brazil.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: